(Q35149415)

6 August 2017

1 reference

title

The immunological basis of psoriasis (English)

1 reference

6 August 2017

1 reference

Griffiths CE

1

1 reference

6 August 2017

1 July 2003

1 reference

Journal of the European Academy of Dermatology and Venereology

6 August 2017

1 reference

6 August 2017

17 Suppl 2

1 reference

6 August 2017

1-5

1 reference

CD69, HLA-DR and the IL-2R identify persistently activated T cells in psoriasis vulgaris lesional skin: blood and skin comparisons by flow cytometry.

6 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.17.S2.1.X

Inflammatory skin diseases, T cells, and immune surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.17.S2.1.X

21 January 2018

Psoriasis: the future

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.17.S2.1.X

A candidate gene for psoriasis near HLA-C, HCR (Pg8), is highly polymorphic with a disease-associated susceptibility allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.17.S2.1.X

The immunologic and genetic basis of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.17.S2.1.X

Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.17.S2.1.X

A major susceptibility locus for atopic dermatitis maps to chromosome 3q21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.17.S2.1.X

Are CD4 antibodies and peptide T new treatments for psoriasis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.17.S2.1.X

CD4 antibody treatment of severe psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.17.S2.1.X

Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.17.S2.1.X

Interleukin 10 treatment of psoriasis: clinical results of a phase 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.17.S2.1.X

Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.17.S2.1.X

10.1046/J.1468-3083.17.S2.1.X

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12795768